Neurontin

Product NDC: 0071-2012
Requested package NDC: 0071-2012-44
11-digit product format: 000712012
Labeler code: 0071
Product ID: 0071-2012_e730d5df-d47b-4d7f-ae3b-bd449f6b1213
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: gabapentin
Dosage form: SOLUTION
Route: ORAL
Labeler: Parke-Davis Div of Pfizer Inc
Application: NDA021129
Marketing category: NDA
Marketing start: 2000-03-02
Marketing end: 2027-01-31
Substance: GABAPENTIN
Active strength: 250 mg/5mL
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag: No
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	0071-2012	0071-2012-44	D	Discontinued by firm		2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N021129-001	NEURONTIN	GABAPENTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
N021129-001	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021129-001	NEURONTIN	250MG/5ML	SOLUTION / ORAL	AA	RLD, RS	2000-03-02	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N021129-001	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N021129-001	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N021129-001	AA	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N021129-001	AA	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N021129-001	AA	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N021129-001	AA	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N021129-001	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N021129-001	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N021129-001	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N021129-001	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N021129-001	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N021129-001	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N021129-001	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N021129-001	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021129-001	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021129-001	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021129-001	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021129-001	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021129-001	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021129-001	AA	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021129-001	AA	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021129-001	AA	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021129-001	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021129-001	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021129-001	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021129-001	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021129-001	AA	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N021129-001	AA	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N021129-001	AA	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N021129-001	AA	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N021129-001	AA	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N021129-001	AA	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N021129-001	AA	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N021129-001	AA	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N021129-001	AA	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N021129-001	AA	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021129-001	AA	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021129-001	AA	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021129-001	AA	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021129-001	AA	1	`cb3db0bc1861…`

Observed Orange Book patent history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021129-001	7256216	2022-05-28	Drug product	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N021129-001	7256216	2022-05-28	Drug product	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N021129-001	7256216	2022-05-28	Drug product	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N021129-001	7256216	2022-05-28	Drug product	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N021129-001	7256216	2022-05-28	Drug product	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N021129-001	7256216	2022-05-28	Drug product	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021129-001	7256216	2022-05-28	Drug product	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N021129-001	7256216	2022-05-28	Drug product	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N021129-001	7256216	2022-05-28	Drug product	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N021129-001	7256216	2022-05-28	Drug product	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N021129-001	7256216	2022-05-28	Drug product	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N021129-001	7256216	2022-05-28	Drug product	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N021129-001	7256216	2022-05-28	Drug product	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`ea99ee380514…`
2023-01-26 05:58 UTC	2023-01	N021129-001	7256216	2022-05-28	Drug product	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021129-001	7256216	2022-05-28	Drug product	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N021129-001	7256216	2022-05-28	Drug product	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N021129-001	7256216	2022-05-28	Drug product	`e64feba35796…`
2022-09-29 23:25 UTC	2022-09	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021129-001	7256216	2022-05-28	Drug product	`cb3db0bc1861…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N021129-001	7256216*PED	2022-11-28	Pediatric extension	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Neurontin

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GABAPENTIN	250 mg/5mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
6CW7F3G59X	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 12 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
105028	Internal RxNorm lookup
105029	Internal RxNorm lookup
105030	Internal RxNorm lookup
261280	Internal RxNorm lookup
261281	Internal RxNorm lookup
283523	Internal RxNorm lookup
310430	Internal RxNorm lookup
310431	Internal RxNorm lookup
310432	Internal RxNorm lookup
310433	Internal RxNorm lookup
310434	Internal RxNorm lookup
351973	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
cdc2ae60-922e-452d-a42f-787fe4e2ed06	Product name	1	20250123
7059096a-4b9f-36c2-db50-bb5c723e6e9e	Product name	2	20250114
fa3f0129-3502-889f-f424-3a37727959e7	Product name	9	20181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2b	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0071-2012-23	Neurontin	470 mL in 1 BOTTLE, GLASS	SOLUTION	470	47
0071-2012-44	Neurontin	470 mL in 1 BOTTLE	SOLUTION	470	47
0071-2012-44	Neurontin	1 in 1 CARTON	SOLUTION	1	47
0071-2012-47	Neurontin	470 mL in 1 BOTTLE, PLASTIC	SOLUTION	470	47
0071-2012-47	Neurontin	1 in 1 CARTON	SOLUTION	1	47

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0071-2012-23	ML - Milliliter	0071-2012	56456e8f-b5ce-45fa-aa6d-f078bfdc1dfd	1	2012-07-24
0071-2012-44	ML - Milliliter	0071-2012	f44b929b-c44b-40aa-8cc6-afd8283b298c	1	2020-02-13
0071-2012-47	ML - Milliliter	0071-2012	515e2c9f-984f-4446-b4ec-c0daa8f54125	1	2022-08-04

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
GABAPENTIN	ACTIVE INGREDIENT	6CW7F3G59X	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
GABAPENTIN	ACTIVE MOIETY	6CW7F3G59X	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
COPOVIDONE K25-31	INACTIVE INGREDIENT	D9C330MD8B	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
GELATIN	INACTIVE INGREDIENT	2G86QN327L	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
POLOXAMER 407	INACTIVE INGREDIENT	TUF2IVW3M2	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
WATER	INACTIVE INGREDIENT	059QF0KO0R	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27
XYLITOL	INACTIVE INGREDIENT	VCQ006KQ1E	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	27

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0071-2012	NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC]	42	Current NDC, Legacy NDC, 5 package rows	20241009_ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Neurontin	GABAPENTIN	Viatris Specialty LLC	97935fd9-1d4a-43b6-a5d9-de994591187b	2026-05-12	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021129 application number: NDA021129
GABAPENTIN	GABAPENTIN	Mylan Pharmaceuticals Inc.	cff7de45-148b-4e96-88fd-6052bf75b5f7	2025-04-12	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021129 application number: NDA021129
Neurontin	GABAPENTIN	Parke-Davis Div of Pfizer Inc	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	2022-07-12	Warnings, Adverse reactions	Exact identifier application applno (NDA): 021129 application number: NDA021129 ndc (package): 0071-2012-44 ndc (product): 0071-2012 ndc11 (package): 00071201244

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
6CW7F3G59X	GABAPENTIN	60142-96-3	GABAPENTIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
310430	gabapentin 100 MG Oral Capsule	PSN	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
283523	gabapentin 250 MG in 5 mL Oral Solution	PSN	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
310431	gabapentin 300 MG Oral Capsule	PSN	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
310432	gabapentin 400 MG Oral Capsule	PSN	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
310433	gabapentin 600 MG Oral Tablet	PSN	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
310434	gabapentin 800 MG Oral Tablet	PSN	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
105028	Neurontin 100 MG Oral Capsule	PSN	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
351973	Neurontin 250 MG in 5 mL Oral Solution	PSN	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
105029	Neurontin 300 MG Oral Capsule	PSN	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
105030	Neurontin 400 MG Oral Capsule	PSN	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
261280	Neurontin 600 MG Oral Tablet	PSN	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
261281	Neurontin 800 MG Oral Tablet	PSN	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
105028	gabapentin 100 MG Oral Capsule [Neurontin]	SBD	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
105029	gabapentin 300 MG Oral Capsule [Neurontin]	SBD	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
105030	gabapentin 400 MG Oral Capsule [Neurontin]	SBD	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
351973	gabapentin 50 MG/ML Oral Solution [Neurontin]	SBD	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
261280	gabapentin 600 MG Oral Tablet [Neurontin]	SBD	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
261281	gabapentin 800 MG Oral Tablet [Neurontin]	SBD	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
310430	gabapentin 100 MG Oral Capsule	SCD	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
310431	gabapentin 300 MG Oral Capsule	SCD	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
310432	gabapentin 400 MG Oral Capsule	SCD	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
283523	gabapentin 50 MG/ML Oral Solution	SCD	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
310433	gabapentin 600 MG Oral Tablet	SCD	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
310434	gabapentin 800 MG Oral Tablet	SCD	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
283523	gabapentin 250 MG per 5 ML Oral Solution	SY	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
283523	gabapentin 300 MG per 6 ML Oral Solution	SY	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
283523	gabapentin 500 MG per 10 ML Oral Solution	SY	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
105028	Neurontin 100 MG Oral Capsule	SY	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
351973	Neurontin 250 MG per 5 ML Oral Solution	SY	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
105029	Neurontin 300 MG Oral Capsule	SY	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
105030	Neurontin 400 MG Oral Capsule	SY	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
351973	Neurontin 50 MG/ML Oral Solution	SY	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
261280	Neurontin 600 MG Oral Tablet	SY	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47
261281	Neurontin 800 MG Oral Tablet	SY	ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388	47

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0071-2012-44	00071201244	1 BOTTLE in 1 CARTON (0071-2012-44) > 470 mL in 1 BOTTLE	1 bottle	2020-01-21	0000-00-00	No	No	Current